An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
The products are far from a proven sleep treatment.
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Fallout 4 took a lot of design risks, including features that fundamentally changed how Bethesda designed open worlds.
This shift has accelerated sharply since 2023, driven by live-service models, Web3 experimentation, and growing regulatory ...
After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...
Physician groups betraying the public’s trust out of fear of government retaliation has permanent consequences,” writes a ...
Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...
FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
Data from EULAR 2026 show that next-generation CAR T- and NK cell platforms induce powerful, drug-free clinical remissions in patients with highly refractory rheumatic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results